News NRG announces £16m Series A for IND for Parkinson’s and ALS A £16 million Series A financing – led by Omega Funds – has been announced by the innovative neuroscience company
News Charity backs R&D into Parkinson's drugs targeting mitochond... The charity Parkinson’s UK has struck a £1 million partnership with NRG Therapeutics to develop drugs targeted at mitochondria that could protect cells producing dopamine, which have been d
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
